{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:21:52Z","timestamp":1778768512680,"version":"3.51.4"},"reference-count":55,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1136\/gutjnl-2014-308724","type":"journal-article","created":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T03:06:28Z","timestamp":1434769588000},"page":"112-123","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design"],"prefix":"10.1136","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-8140","authenticated-orcid":false,"given":"Annette","family":"von Delft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isla S","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Pfafferott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg M","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Gaudieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"key-10.1136\/gutjnl-2014-308724-1","unstructured":"WHO H. WHO | Hepatitis C. WHO. 2014. http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/ (accessed 16 Jan 2014)."},{"issue":"(Suppl 2)","key":"key-10.1136\/gutjnl-2014-308724-2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1478-3231.2011.02537.x","article-title":"The global health burden of hepatitis C virus infection","volume":"31","author":"Negro","year":"2011","journal-title":"Liver Int"},{"key":"key-10.1136\/gutjnl-2014-308724-3","first-page":"1","article-title":"Chronic hepatitis C: future treatment","volume":"6","author":"Wendt","year":"2014","journal-title":"Clin Pharmacol"},{"key":"key-10.1136\/gutjnl-2014-308724-4","unstructured":"NICE guidlines for Boceprevir and Telaprevir. NICE publishes final guidance on two new drugs for chronic hepatitis C. NICE. 2013. http:\/\/www.nice.org.uk\/ (accessed 16 Jan 2014)."},{"key":"key-10.1136\/gutjnl-2014-308724-5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus Sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.1136\/gutjnl-2014-308724-6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.gastro.2014.05.010","article-title":"Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man","volume":"147","author":"Franco","year":"2014","journal-title":"Gastroenterology"},{"key":"key-10.1136\/gutjnl-2014-308724-7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0031-1297925","article-title":"New insights into the HCV quasispecies and compartmentalization","volume":"31","author":"Farci","year":"2011","journal-title":"Semin Liver Dis"},{"key":"key-10.1136\/gutjnl-2014-308724-9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-10","first-page":"1","volume-title":"Hepatitis C in the UK: annual report 2012","author":"Health Protection Agency","year":"2012"},{"key":"key-10.1136\/gutjnl-2014-308724-11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.meegid.2004.08.001","article-title":"The hepatitis C virus epidemic among injecting drug users","volume":"5","author":"Pybus","year":"2005","journal-title":"Infect Genet Evol"},{"key":"key-10.1136\/gutjnl-2014-308724-12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/jmv.20692","article-title":"Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users","volume":"78","author":"Morice","year":"2006","journal-title":"J Med Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3748\/wjg.14.1237","article-title":"Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006","volume":"14","author":"Roman","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key-10.1136\/gutjnl-2014-308724-14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat Med"},{"key":"key-10.1136\/gutjnl-2014-308724-15","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"key-10.1136\/gutjnl-2014-308724-16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23101","article-title":"Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure","volume":"50","author":"Rauch","year":"2009","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.23096","article-title":"Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3","volume":"50","author":"Giugliano","year":"2009","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1136\/gutjnl-2011-300650","article-title":"HCV genotype-3a T cell immunity: specificity, function and impact of therapy","volume":"61","author":"Humphreys","year":"2012","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2014-308724-19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/gut.2005.072231","article-title":"Relation between viral fitness and immune escape within the hepatitis C virus protease","volume":"55","author":"S\u00f6derholm","year":"2006","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2014-308724-20","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/JVI.01700-07","article-title":"Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level","volume":"82","author":"Neumann-Haefelin","year":"2008","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-21","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1016\/j.vaccine.2008.05.045","article-title":"Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073","volume":"26","author":"Fytili","year":"2008","journal-title":"Vaccine"},{"key":"key-10.1136\/gutjnl-2014-308724-22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2249.2003.02033.x","article-title":"Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection","volume":"131","author":"Harcourt","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"key-10.1136\/gutjnl-2014-308724-23","first-page":"1437","article-title":"Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection","volume":"38","author":"Sugimoto","year":"2003","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","article-title":"Cross-genotype immunity to hepatitis C virus","volume":"78","author":"Lanford","year":"2004","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/496889","article-title":"Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model","volume":"192","author":"Prince","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.1136\/gutjnl-2014-308724-26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"key-10.1136\/gutjnl-2014-308724-27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2007-01-069583","article-title":"Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non\u2013genotype 1 infection","volume":"110","author":"Schulze zur Wiesch","year":"2007","journal-title":"Blood"},{"key":"key-10.1136\/gutjnl-2014-308724-28","first-page":"380","article-title":"Vertical T cell immunodominance and epitope entropy determine HIV-1 escape","volume":"123","author":"Liu","year":"2013","journal-title":"J Clin Invest"},{"key":"key-10.1136\/gutjnl-2014-308724-29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"key-10.1136\/gutjnl-2014-308724-30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00002030-200404090-00004","article-title":"Impact of intrapeptide epitope location on CD8T cell recognition: implications for design of overlapping peptide panels","volume":"18","author":"Draenert","year":"2004","journal-title":"AIDS"},{"key":"key-10.1136\/gutjnl-2014-308724-31","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/428578","article-title":"Prospective evaluation of community-acquired acute-phase hepatitis C virus infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"(Pt 6)","key":"key-10.1136\/gutjnl-2014-308724-32","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1099\/vir.0.051052-0","article-title":"\u2018Favourable\u2019 IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype-3a infection and do not predict sustained virological response after 24 weeks of therapy","volume":"94","author":"Bucci","year":"2013","journal-title":"J Gen Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/597072","article-title":"Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection","volume":"199","author":"Barnes","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.1136\/gutjnl-2014-308724-34","doi-asserted-by":"crossref","first-page":"11456","DOI":"10.1128\/JVI.00884-09","article-title":"Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection","volume":"83","author":"Humphreys","year":"2009","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2004.06.015","article-title":"High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection","volume":"127","author":"Lauer","year":"2004","journal-title":"Gastroenterology"},{"key":"key-10.1136\/gutjnl-2014-308724-36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.20749","article-title":"Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C","volume":"42","author":"Cox","year":"2005","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-37","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1128\/JVI.76.12.6104-6113.2002","article-title":"Comprehensive analysis of CD8+-T-Cell responses against hepatitis C virus reveals multiple unpredicted specificities","volume":"76","author":"Lauer","year":"2002","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-38","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1099\/vir.0.017699-0","article-title":"Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection","volume":"91","author":"Fleming","year":"2010","journal-title":"J Gen Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/jhep.2003.50115","article-title":"Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection","volume":"37","author":"Wertheimer","year":"2003","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-40","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1128\/JVI.00995-07","article-title":"Viral sequence evolution in acute hepatitis C virus infection","volume":"81","author":"Kuntzen","year":"2007","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.hepres.2006.08.011","article-title":"Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epiotpe in NS3 region","volume":"36","author":"Ito","year":"2006","journal-title":"Hepatol Res"},{"key":"key-10.1136\/gutjnl-2014-308724-42","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JVI.02252-07","article-title":"Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance","volume":"82","author":"Yerly","year":"2008","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/hep.23319","article-title":"Selection-driven immune escape is not a significant factor in the failure of CD4T cell responses in persistent hepatitis C virus infection","volume":"51","author":"Fuller","year":"2010","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","article-title":"A mathematical theory of communication","volume":"27","author":"Shannon","year":"1948","journal-title":"Bell Syst Tech J"},{"key":"key-10.1136\/gutjnl-2014-308724-45","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/hep.26905","article-title":"Is the genotype 3 of the hepatitis C virus the new villain?","volume":"59","author":"Goossens","year":"2014","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2014-308724-46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/jvh.12168","article-title":"Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3","volume":"20","author":"Tapper","year":"2013","journal-title":"J Viral Hepat"},{"key":"key-10.1136\/gutjnl-2014-308724-47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"key-10.1136\/gutjnl-2014-308724-48","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1086\/315450","article-title":"Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C","volume":"181","author":"Gr\u00fcner","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.1136\/gutjnl-2014-308724-49","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"J Exp Med"},{"key":"key-10.1136\/gutjnl-2014-308724-50","doi-asserted-by":"crossref","first-page":"e101264","DOI":"10.1371\/journal.pone.0101264","article-title":"Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects","volume":"9","author":"Galal","year":"2014","journal-title":"PLoS ONE"},{"key":"key-10.1136\/gutjnl-2014-308724-51","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"key-10.1136\/gutjnl-2014-308724-52","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1128\/JVI.01911-14","article-title":"Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization","volume":"88","author":"Wong","year":"2014","journal-title":"J Virol"},{"key":"key-10.1136\/gutjnl-2014-308724-53","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.4049\/jimmunol.1103008","article-title":"Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection","volume":"188","author":"Burke","year":"2012","journal-title":"J Immunol"},{"key":"key-10.1136\/gutjnl-2014-308724-54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/eji.201444686","article-title":"Cross-reactivity of hepatitis C virus-specific vaccine induced T cells at immunodominant epitopes","volume":"45","author":"Kelly","year":"2015","journal-title":"Eur J Immunol"},{"key":"key-10.1136\/gutjnl-2014-308724-55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"Fischer","year":"2007","journal-title":"Nat Med"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2014-308724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:59:30Z","timestamp":1601085570000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2014-308724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,8]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/gutjnl-2014-308724"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2014-308724","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,19]]}}}